Jenrin Discovery Overview
- Year Founded
-
2004
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Jenrin Discovery General Information
Description
Developer of small-molecule drugs intended to offer therapeutics for various chronic diseases. The company's drugs offer to treat chronic diseases, including diabetes, nonalcoholic steatohepatitis, and obesity, enabling physicians to treat their patients in an enhanced way.
Contact Information
Website
www.jenrindiscovery.comCorporate Office
- 1193 Killarney Lane
- West Chester
- PA 19382
- United States
Corporate Office
- 1193 Killarney Lane
- West Chester
- PA 19382
- United States
Jenrin Discovery Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Out of Business | 13-Jun-2025 | Completed | Out of Business | |||
| 7. Later Stage VC | 25-Apr-2018 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 09-Nov-2016 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series B) | 01-Mar-2012 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 02-Mar-2010 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 03-Jun-2008 | Completed | Generating Revenue | |||
| 2. Grant | $1.25M | Completed | Generating Revenue | |||
| 1. Seed Round | 18-Mar-2005 | Completed | Generating Revenue |
Jenrin Discovery Comparisons
Industry
Financing
Details
Jenrin Discovery Competitors (3)
One of Jenrin Discovery’s 3 competitors is Intercept Pharmaceuticals, a Formerly VC-backed company based in Morristown, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Intercept Pharmaceuticals | Formerly VC-backed | Morristown, NJ | ||||
| Gilead | Formerly VC-backed | Foster City, CA | ||||
| Madrigal Pharmaceuticals | Formerly VC-backed | West Conshohocken, PA |
Jenrin Discovery Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Jenrin Discovery Patents
Jenrin Discovery Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2015523396-A | Cannabinoid receptor antagonist / inverse agonist | Active | 25-Jul-2012 | ||
| JP-6249534-B2 | Cannabinoid receptor antagonist / inverse agonist | Inactive | 25-Jul-2012 | ||
| AU-2013295741-A1 | Cannabinoid receptor antagonists/inverse agonists | Active | 25-Jul-2012 | ||
| AU-2013295741-B2 | Cannabinoid receptor antagonists/inverse agonists | Inactive | 25-Jul-2012 | ||
| CA-2879741-A1 | Cannabinoid receptor antagonists/inverse agonists | Active | 25-Jul-2012 | A61K31/415 |
Jenrin Discovery FAQs
-
When was Jenrin Discovery founded?
Jenrin Discovery was founded in 2004.
-
Where is Jenrin Discovery headquartered?
Jenrin Discovery is headquartered in PA.
-
What industry is Jenrin Discovery in?
Jenrin Discovery’s primary industry is Drug Discovery.
-
Is Jenrin Discovery a private or public company?
Jenrin Discovery is a Private company.
-
What is Jenrin Discovery’s current revenue?
The current revenue for Jenrin Discovery is .
-
How much funding has Jenrin Discovery raised over time?
Jenrin Discovery has raised $7.6M.
-
Who are Jenrin Discovery’s competitors?
Intercept Pharmaceuticals, Gilead, and Madrigal Pharmaceuticals are competitors of Jenrin Discovery.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
